An audit of the use of high dose neuroleptics in treating schizophrenia

被引：0
|
作者：
Tyson, PJ [1 ]
Mortimer, A [1 ]
Wheeler, JA [1 ]
机构：
[1] Univ Hull, Dept Psychiat, Hull HU10 6ED, N Humberside, England
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88700-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [31] Naltrexone augmentation of neuroleptics in schizophrenia
    Sernyak, MJ
    Glazer, WM
    Heninger, GR
    Charney, DS
    Woods, SW
    Petrakis, IL
    Krystal, JH
    Price, LH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (03) : 248 - 251
  • [32] Use experience of high dose olanzapine in patients with poorly responding schizophrenia
    Akahane, A.
    Hata, T.
    Nanko, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 151 - 151
  • [33] Subjective response to neuroleptics in schizophrenia
    Arango, C
    Sanz, M
    Garcia, I
    Gonzalez, M
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 263 - 264
  • [34] THE DOSAGE OF NEUROLEPTICS IN ACUTE SCHIZOPHRENIA
    KLIESER, E
    LEHMANN, E
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1988, 130 (41): : 708 - 711
  • [35] Use of conventional antipsychotics and the cost of treating schizophrenia
    Lyu, RR
    McCombs, JS
    Johnstone, BM
    Muse, DN
    HEALTH CARE FINANCING REVIEW, 2001, 23 (02): : 83 - 99
  • [36] Effect of smoking on neuroleptics in schizophrenia
    Salokangas, RKR
    Saarijarvi, S
    Taiminen, T
    Lehto, H
    Niemi, H
    Ahola, V
    Syvalahti, E
    SCHIZOPHRENIA RESEARCH, 1997, 23 (01) : 55 - 60
  • [37] Treating comorbid substance use disorders in schizophrenia
    Lubman, Dan I.
    King, Joel A.
    Castle, David J.
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2010, 22 (02) : 191 - 201
  • [38] HIGH-DOSE CORTICOSTEROIDS - THEIR USE IN TREATING IDIOPATHIC RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS
    ONEILL, WM
    ETHERIDGE, WB
    BLOOMER, HA
    ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (05) : 514 - 518
  • [39] THE USE OF HIGH-DOSES OF NEUROLEPTICS - THE CURRENT SITUATION
    KING, DJ
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 (02) : 75 - 78
  • [40] DOSE-FINDING TRIAL OF D-CYCLOSERINE ADDED TO NEUROLEPTICS FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    GOFF, DC
    TSAI, GC
    MANOACH, DS
    COYLE, JT
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (08): : 1213 - 1215
12345